Yongbing Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 18
- Advanced biosensing and bioanalysis techniques 12
-
- Lung Cancer Diagnosis and Treatment 30
- Lung Cancer Treatments and Mutations 19
- Co-authors
- Lichen Yin (27 shared papers)Rongying Zhu (27 shared papers)Shanzhou Duan (33 shared papers)Donglai Chen (47 shared papers)Huan Ye (5 shared papers)Mingjing Shen (11 shared papers)Hua He (4 shared papers)Ziyin Zhao (8 shared papers)
- Journals
- Biomaterials Science (6 papers)Lung Cancer (5 papers)Oncotarget (5 papers)European Journal of Cardio-Thoracic Surgery (4 papers)Cancer Management and Research (3 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Yongbing Chen
161 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 146
- Cancer Research 537
- Biomaterials 432
- Pulmonary and Respiratory Medicine 849
- Oncology 673
- Molecular Biology 1.4k
Countries citing papers authored by Yongbing Chen
This map shows the geographic impact of Yongbing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongbing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongbing Chen more than expected).
Fields of papers citing papers by Yongbing Chen
This network shows the impact of papers produced by Yongbing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongbing Chen. The network helps show where Yongbing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yongbing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 209 | |
| 2 | 2019 | 157 | |
| 3 | 2018 | 114 | |
| 4 | 2018 | 103 | |
| 5 | 2021 | 84 | |
| 6 | 2018 | 84 | |
| 7 | 2015 | 84 | |
| 8 | 2017 | 83 | |
| 9 | 2023 | 81 | |
| 10 | 2021 | 75 | |
| 11 | 2019 | 65 | |
| 12 | 2022 | 62 | |
| 13 | 2017 | 62 | |
| 14 | 2015 | 61 | |
| 15 | 2019 | 55 | |
| 16 | 2017 | 52 | |
| 17 | 2021 | 51 | |
| 18 | 2016 | 50 | |
| 19 | 2016 | 50 | |
| 20 | 2018 | 50 |
About Yongbing Chen
Yongbing Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Cancer Research, having authored 176 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (30 papers), Lung Cancer Treatments and Mutations (19 papers), RNA Interference and Gene Delivery (18 papers), Cancer Immunotherapy and Biomarkers (14 papers), Esophageal Cancer Research and Treatment (14 papers), Advanced biosensing and bioanalysis techniques (12 papers), Nanoplatforms for cancer theranostics (11 papers) and MicroRNA in disease regulation (11 papers). The work is most often cited by research in Cancer Research (537 citations), Biomaterials (432 citations), Pulmonary and Respiratory Medicine (849 citations), Oncology (673 citations) and Molecular Biology (1.4k citations). Yongbing Chen has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Lichen Yin, Rongying Zhu, Shanzhou Duan, Donglai Chen, Huan Ye, Mingjing Shen, Hua He, Ziyin Zhao, Yong Liu and Xuejie Wu. Their work appears in journals such as Biomaterials Science, Lung Cancer, Oncotarget, European Journal of Cardio-Thoracic Surgery and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.